Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion type Assertion NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_head.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion wasGeneratedBy ECO_0000203 NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_provenance.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion wasDerivedFrom befree-20140225 NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_provenance.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion SIO_000772 9589681 NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_provenance.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion evidence source_evidence_literature NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_provenance.
- NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_assertion description "[To further investigate this role, the IGF/IGF-binding protein (IGFBP) system was analyzed in 18 adrenocortical tumors, classified into 2 groups on the basis of their IGF-II messenger ribonucleic acid (mRNA) content (group 1, normal IGF-II mRNA content, mostly benign tumors; group 2, high IGF-II mRNA content, mostly malignant tumors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611656.RAQK0CWtoKu_bOam-aw9wHpf9DatibEYQWUfC7pI9GFvs130_provenance.